Fibrinogen Turnover in Progressive Systemic Sclerosis
Open Access
- 1 April 1978
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 21 (3) , 343-347
- https://doi.org/10.1002/art.1780210309
Abstract
Large amounts of fibrin are seen in the intima of the renal arterioles in progressive systemic sclerosis (scleroderma). The half-life or half disappearance time of plasma fibrinogen in 15 patients with scleroderma was studied using 125I fibrinogen to find whether there is an increased turnover of plasma fibrinogen paralleling this morphologic abnormality. Patients had a more rapid fibrinogen turnover than normal controls (60.7 versus 90.6 hours); the subgroup of patients with “progressive” scleroderma had a more rapid fibrinogen half-life than those with “stable” scleroderma (56.5 versus 73.2 hours). The mean fibrinogen half-life of 8 patients given intravenous heparin increased to within one standard deviation of normal, a finding that suggested that the fibrinogen molecule in these patients was capable of normal survival. There was a considerable variation of fibrinogen half-lives in individual scleroderma patients over time (not seen in the normal controls) which may be the result of intermittently increased fibrinogen consumption.Keywords
This publication has 13 references indexed in Scilit:
- The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.Journal of Clinical Investigation, 1976
- Fibrinogen catabolism in systemic lupus erythematosusArthritis & Rheumatism, 1976
- Pathogenesis of systemic sclerosis: A vascular hypothesisSeminars in Arthritis and Rheumatism, 1975
- Participation of intravascular coagulation in the pathogenesis of glomerular and vascular lesionsKidney International, 1975
- Patterns of finger capillary abnormalities in connective tissue disease by “wide‐field” microscopyArthritis & Rheumatism, 1973
- Scleroderma and Microangiopathic Hemolytic AnemiaAnnals of Internal Medicine, 1973
- Metabolism and Distribution of Fibrinogen. I. FIBRINOGEN TURNOVER IN PHYSIOLOGICAL CONDITIONS IN HUMANSBritish Journal of Haematology, 1972
- Measurement of Serum DNA-Binding Activity in Systemic Lupus ErythematosusNew England Journal of Medicine, 1969
- IN VIVO BEHAVIOR OF I131-FIBRINOGENJournal of Clinical Investigation, 1963